Correction to: Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20?mg/5?mg/12.5?mg fixed-dose combination in hypertension: a profile of its use

Katherine A. Lyseng-Williamson

首页> 外文期刊>Drugs & therapy perspectives: for rational drug selection and use >Correction to: Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20?mg/5?mg/12.5?mg fixed-dose combination in hypertension: a profile of its use

【24h】

Correction to: Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20?mg/5?mg/12.5?mg fixed-dose combination in hypertension: a profile of its use

机译：校正至：Olmesartan Medoxomil /氨氯氨嗪/氢氯噻嗪20？Mg / 5？Mg / 12.5？Mg固定剂组合在高血压中：其使用的剖面

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Page 2, column 2, section “What is the clinical efficacy of OLM/AMT/HCT 20?mg/5?mg/12.5?mg?”, paragraph 1, lines 5–8: The following text, which previously read.

机译：Page 2，第2栏，部分“OLM / AMT / HCT 20的临床疗效是什么？MG / 5？MG / 12.5？MG？”，第1条，第5-8行：以下文本，先前读取。

著录项

来源
《Drugs & therapy perspectives: for rational drug selection and use》 |2018年第7期|共1页
作者
Katherine A. Lyseng-Williamson;
展开▼
作者单位

Springer;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Correction to: Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20?mg/5?mg/12.5?mg fixed-dose combination in hypertension: a profile of its use [J] . Katherine A. Lyseng-Williamson Drugs & therapy perspectives: for rational drug selection and use . 2018,第7期

机译：校正至：Olmesartan Medoxomil /氨氯氨嗪/氢氯噻嗪20？Mg / 5？Mg / 12.5？Mg固定剂组合在高血压中：其使用的剖面
2. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial (vol 16, pg 129, 2016) [J] . Sohn Il Suk, Kim Chong-Jin, Oh Byung-Hee, SIAM journal on applied dynamical systems . 2017,第2期

机译：高血压患者Olmesartan Medoxomil，氨氯沙宁和氢氯噻嗪组合治疗的疗效和安全性研究不受奥米腊肠和盐酸盐组合治疗：随机，双盲，多中心试验的结果（Vol 16，PG 129,2016）
3. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial [J] . Sohn Il Suk, Kim Chong-Jin, Oh Byung-Hee, SIAM journal on applied dynamical systems . 2017,第2期

机译：高血压患者奥姆塞尔坦麦克斯麦昔米尔，氨氯沙宁和氢氯噻嗪联合治疗的疗效和安全性研究不受奥米腊肠和氢氯噻嗪组合治疗：随机，双盲，多中心试验的结果
4. Aliskiren Alone or in Combination With Hydrochlorothiazide in Patients With the Lower Ranges of Stage 2 Hypertension: The ACQUIRE Randomized Double-Blind Study [C] . Henry R. Black, Andreas Kribben, Ferno Aguirre Palacios, World Congress on Heart Disease . 2011

机译：单独的Aliskiren或与氢氯噻嗪的患者组合，患者2阶段的2阶段高血压：ACCOMINE随机双盲研究
5. Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized Double-Blind Multicenter Trial [O] . Il Suk Sohn, Chong-Jin Kim, Byung-Hee Oh, -1

机译：勘误至：奥美沙坦美多索密氨氯地平和氢氯噻嗪联合治疗无法控制的高血压患者的疗效和安全性研究：一项随机双盲多中心试验的结果
6. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial [O] . 2016

机译：奥美沙坦联合氨氯地平和氢氯噻嗪联合治疗不能控制的高血压患者的疗效和安全性研究：一项随机，双盲，多中心试验的结果

Correction to: Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20?mg/5?mg/12.5?mg fixed-dose combination in hypertension: a profile of its use

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅